← Back to Search

Interactive 3D Tool for Breast Reconstruction Consultation

N/A

Waitlist Available

Led By Carrie Stern, MD

Research Sponsored by Memorial Sloan Kettering Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Planning to undergo mastectomy at time of consultation

Presenting at MSK for initial breast reconstruction consultation

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months after surgery

Awards & highlights

Study Summary

This trial will test whether using a 3D tool during a breast reconstruction consultation can lead to greater patient satisfaction.

Who is the study for?

This trial is for women over 18 who speak English as their primary language, coming to MSK for their first breast reconstruction consultation and planning a mastectomy. It's not open to those who've had previous consultations or reconstructions.Check my eligibility

What is being tested?

The study is testing if an interactive 3D tool used during the surgical consultation can improve patient satisfaction with information about breast reconstruction options compared to standard consultations without the tool.See study design

What are the potential side effects?

There are no direct medical side effects from participating in this trial since it involves non-invasive tools like the interactive 3D model and questionnaires assessing satisfaction and decision-making.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am planning to have a mastectomy.

Select...

I am at MSK for my first breast reconstruction consultation.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months after surgery

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months after surgery

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Secondary outcome measures

BREAST-Q Satisfaction

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Standard consultation with interactive 3D visualizationExperimental Treatment4 Interventions

Participants in this group will use the interactive 3D tool in addition to receiving the standard surgical consultation before their breast reconstruction procedure.

Group II: Standard consultationActive Control3 Interventions

Participants in this group will receive a standard surgical consultation before their breast reconstruction procedure.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor

1,933 Previous Clinical Trials

585,534 Total Patients Enrolled

202 Trials studying Breast Cancer

81,049 Patients Enrolled for Breast Cancer

Carrie Stern, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the overall participation rate for this clinical trial?

"Affirmative. Reports on clinicaltrials.gov indicate that the trial, which was initially posted in August 2021, is actively recruiting patients at this time. 88 participants are being enrolled from a single site."

Answered by AI

Are researchers still looking for new participants in this trial?

"Affirmative. Clinicaltrials.gov showcases that this medical study, first posted on August 23rd 2021, is currently seeking participants. 88 patients must be enrolled from a single site for the trial to reach its full capacity."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Use of an Interactive 3D Tool During Consultation for Breast Reconstruction Surgery

2021. "Use of an Interactive 3D Tool During Consultation for Breast Reconstruction Surgery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05025020.